Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Endocrine, metabolic & immune disorders drug targets 2019-Feb

Effect of Fractions of Vernonia amygdalina on Some Biochemical Parameters in High Fat Diet Induced Obese Rats.

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
Chima Egedigwe-Ekeleme
Ifeoma Ijeh
Polycarp Okafor
Chinedum Eleazu
Uchenna Egedigwe

Avainsanat

Abstrakti

No study till date has reported the effect of fractions of Vernonia amygdalina on obese animals as a way of developing novel drugs for the treatment of obesity.To investigate the effect of fractions (F1-F5) from methanol extract of Vernonia amygdalina (VA) on high fat diet induced obese rats.Methanol extract of VA was fractionated using a column. After twelve weeks of obesity induction, forty-eight male wistar rats were randomly distributed into eight groups. Groups A-E received fractions F1-F5; group F received orlistat (positive control); group G received high fat diet (negative control). Following 4 weeks of administration of the fractions, the total cholesterol, triacylglycerol, High Density Lipoprotein Cholesterol (HDL-c), Very Low-Density Lipoprotein Cholesterol (VLDL-c), blood glucose, body weight, relative liver, kidney, spleen and intestinal weights, serum amylase, intestinal amylase, pancreatic lipase activities, insulin, leptin and adiponectin concentrations of the rats were measured.There were significant decreases (P<0.05) in the relative liver weights (3.2 g/100 g), HDL-c (13.99 mg/dL) and adiponectin (0.18 ng/mL) concentrations, no significant differences in the relative kidney (0.67 g/100 g), spleen (0.20 g/100 g) and intestinal weights (5.3 g/100 g) but significant increases (P<0.05) in the VLDL-c (45.78 mg/dl), triacylglycerol (228.93 mg/dL) concentrations, coronary and cardiovascular risk indices (16.10 and 16.36 respectively expressed as ratios), serum and intestinal amylase (264.42 and 120.73 U/L respectively), and serum lipase activities (43.37 U/L), insulin (1.55 ng/mL), leptin (0.027 pg/mL), glucose and body weights of the negative control compared with the positive control. Fractions F4 or F5 positively modulated most of these parameters better than fractions F1 to F3 in a manner that was close to orlistat.Modulation of HFD induced obesity by fractions F4 and F5 suggests their potentials as useful agents for the management of obesity.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge